Trial Profile
A Prospective Randomized Multi-Center Comparison of the CYPHER Select Sirolimus-Eluting Stent and Balloon Re-Angioplasty for Treatment of Patients With Intra-Des Restenosis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Oct 2010
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms CRISTAL
- Sponsors Cordis Corporation
- 21 Sep 2010 Primary endpoint 'Late lumen loss' has not been met, according to results presented at the 22nd Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
- 21 Sep 2010 Results presented at the 22nd Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
- 28 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.